Quick Answer
BioAge Labs, Inc. reported Shares Outstanding of 37.39 million shares for fiscal year 2025.
BioAge Labs, Inc. Shares Outstanding — Annual History
| Fiscal Year | Shares Outstanding | YoY Change |
|---|---|---|
| 2025 | 37.39M | +4.3% |
| 2024 | 35.85M | +2042.5% |
| 2023 | 1.67M | — |
Quarterly Shares Outstanding
| Quarter Ending | Shares Outstanding | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | 35.85M | +4.8% | +0.0% |
| June 30, 2025 | 35.85M | — | +0.0% |
| March 31, 2025 | 35.85M | — | +0.0% |
| December 31, 2024 | 35.85M | +2042.5% | +4.8% |
| September 30, 2024 | 34.20M | — | +1943.7% |
| December 31, 2023 | 1.67M | — | — |
- BioAge Labs, Inc. showed an increase of +4.3% in Shares Outstanding compared to the prior fiscal year.
- Over the 2023–2025 period, BioAge Labs, Inc.’s shares outstanding has grown by 2134.3% (from 1.67 million shares to 37.39 million shares).
- The most recent figure is from BioAge Labs, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 24, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: